GSK is forming a consumer health joint venture with Novartis, while at the same time buying the Swiss company’s vaccines business and divesting its cancer drugs portfolio to Novartis

GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.G(...)

Microsoft: results today. Photograph: Justin Sullivan/Getty Images
For your diary

TODAY Results: Crane; Microsoft; Sanmina. Meetings: Hostelworld conference (Convention Centre Dublin). Indicators: Euro zone retail sales (D(...)

Kinsale has a great deal going for it. By the sea, it has a reputation as the gourmet capital of Ireland. It is a postcard-pretty village in the he(...)

EU antitrust regulators have approved US drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business. Photo: Reuters

EU antitrust regulators approved US drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business on Friday.The Europea(...)

Joe Jimenez: refocusing Novartis on pharmaceuticals, eyecare and generics

A near $50 billion (€36 billion) takeover battle for the maker of Botox and a multibillion-dollar asset swap between Novartis and Glaxo-SmithKline (...)

AstraZeneca shares surged by 8 per cent at one stage amid frenzied speculation that US rival Pfizer was preparing a mega-bid. Photograph: Chris Ratcliffe/Bloomberg

A flurry of deals and speculation of more to come has set the pharmaceuticals sector alight, sending shares in some of the UK’s biggest drugs g(...)

Eli Lilly said the deal is not expected to change its dividend policy or current share repurchase programme

Eli Lilly has confirmed it will buy Swiss drugmaker Novartis AG’s animal health business for $5.4 billion in cash to strengthen and diversify (...)

Netflix: results out today. Photograph: Gareth Cattermole/Getty Images for Netflix
For your diary

TODAY Results: Burger King; CBRE; First Bancorp; GNC Holdings; Hasbro; Netflix. Indicators: US Chicago Fed national activity index (Apr). (...)

Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts lavish parties for (...)

Takeda Pharmaceutical’s shares fell as much as 8.8 per cent to an eight-month low in Tokyo trading today after the US federal jury verdict. Photograph: Kiyoshi Ota/Bloomberg

Takeda Pharmaceutical said it would contest $6 billion in punitive damages imposed by a US federal jury in a case alleging Japan’s largest drug(...)